tNGS in pediatric LRTIs shows higher Mycoplasma pneumoniae detection in severe vs non-severe CAP
This retrospective, single-center cohort study analyzed 2,299 children with suspected lower respiratory tract infections, including 1,845 community-acquired pneumonia (CAP) patients (293 with severe CAP [SCAP] and 1,552 with non-severe CAP [nsCAP]). The intervention involved targeted next-generation sequencing (tNGS) of throat swab samples to assess pathogen profiles and associations with disease severity, with no comparator reported. Main results showed a higher detection rate of Mycoplasma pneumoniae in SCAP (35.8%) compared to nsCAP (8.9%), with a P value reported but the exact value cut off in the text; other outcomes included microbial diversity indices and relative abundance of species, but absolute numbers and effect sizes were not reported. Safety and tolerability data were not reported, and key limitations include the inherent limitations of traditional diagnostic methods in comprehensively assessing the etiological spectrum and microecological characteristics of pediatric LRTIs, along with the retrospective, single-center design. In practice, these findings highlight potential associations but do not establish causality, suggesting tNGS may offer insights into pathogen profiles in pediatric LRTIs, though clinical relevance remains uncertain without follow-up or safety data.